• Overview
  • Eligibility
  • More info
  • Locations

3.2 mm Diameter Implants and Soft Tissue Grafts in Alternative to Horizontal Bone Augmentation for Placing 4.2 mm Diameter Implants at Central Incisors. A Multicenter Randomised Controlled Trial (NCT02897193)

Horizontal bone augmentation procedures are commonly used to increase bone width to allow the placement of dental implants or to improve aesthetics in deficient areas. Smaller diameter implants could be used instead in order to avoid bone augmentation procedures. The comparison between these two solutions will be evaluated in the trial.
  • Device: ICE dental implant 4.2 mm
    ICE dental implant 4.2 mm diameter
    • Device: NICE dental implant 3.2 mm
      NICE dental implant 4.2 mm diameter
      • Device: Alpha Bio's Graft Bovine bone
        Alpha Bio's Graft Bovine Bone
        • Device: Alpha Bio's Graft resorbable membrane
          Alpha Bio's Graft resorbable collagen membrane
          Ages eligible for Study
          18 Years and older
          Genders eligible for Study
          Accepts Healthy Volunteers
          Inclusion Criteria:
          • Upper central incisor edentulism
          • bone width between 3.5-4.5 mm
          • requirement of only one implant supported crown
          • patient is willing to sign an informed consent
          Exclusion Criteria:
          • General contraindications to implant surgery.
          • Immunosuppressed or immunocompromised patients
          • Patients irradiated in the head and neck area.
          • Patients with poor oral hygiene and motivation.
          • Uncontrolled diabetes.
          • Pregnancy or lactation.
          • Addiction to alcohol or drugs.
          • Untreated periodontal disease.
          • Treated or under treatment with intravenous amino-biphosphonates.
          • Poor oral hygiene and motivation.
          • Psychiatric problems and/or unrealistic expectations.
          • Acute infection (abscess) or suppuration in the area intended for implant placement.
          • Patients referred only for implant placement if cannot be followed at the treatment centre.
          • Patient unable to attend the follow-up controls for 3 years after implant loading.
          • Patient included in other studies, if this protocol cannot be properly followed.
          • Immediate post-extractive sites (to be eligible at least 3 months must have passed since extraction).

          2 locations

          Chile (2)
          • University of Antofagasta
            Antofagasta, Chile
          • Andrés Bello National University
            Santiago, Chile
          31 July, 2016
          21 September, 2016
          A girl giving information about available additional trials.

          FindMeCure helps you find, understand and join clinical trials from all over the world.

          There are more clinical trials for your condition!